- Home
- ELDN vs RCMT Comparison
ELDN vs RCMT Comparison
Compare ELDN & RCMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- RCMT
- Stock Information
- Founded
- ELDN 2004
- RCMT 1971
- Country
- ELDN United States
- RCMT United States
- Employees
- ELDN N/A
- RCMT N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- RCMT Professional Services
- Sector
- ELDN Health Care
- RCMT Consumer Discretionary
- Exchange
- ELDN Nasdaq
- RCMT Nasdaq
- Market Cap
- ELDN 140.3M
- RCMT 165.8M
- IPO Year
- ELDN N/A
- RCMT N/A
- Fundamental
- Price
- ELDN $4.07
- RCMT $21.53
- Analyst Decision
- ELDN Strong Buy
- RCMT Strong Buy
- Analyst Count
- ELDN 1
- RCMT 2
- Target Price
- ELDN $16.00
- RCMT $37.00
- AVG Volume (30 Days)
- ELDN 1.0M
- RCMT 52.6K
- Earning Date
- ELDN 11-12-2024
- RCMT 11-07-2024
- Dividend Yield
- ELDN N/A
- RCMT N/A
- EPS Growth
- ELDN N/A
- RCMT 7.73
- EPS
- ELDN N/A
- RCMT 1.95
- Revenue
- ELDN N/A
- RCMT $272,496,000.00
- Revenue This Year
- ELDN N/A
- RCMT $7.65
- Revenue Next Year
- ELDN N/A
- RCMT $9.33
- P/E Ratio
- ELDN N/A
- RCMT $11.04
- Revenue Growth
- ELDN N/A
- RCMT 3.84
- 52 Week Low
- ELDN $1.11
- RCMT $17.11
- 52 Week High
- ELDN $5.54
- RCMT $32.15
- Technical
- Relative Strength Index (RSI)
- ELDN 51.95
- RCMT 44.80
- Support Level
- ELDN $3.76
- RCMT $20.93
- Resistance Level
- ELDN $4.17
- RCMT $22.24
- Average True Range (ATR)
- ELDN 0.39
- RCMT 1.10
- MACD
- ELDN -0.15
- RCMT -0.32
- Stochastic Oscillator
- ELDN 18.45
- RCMT 11.03
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Engineering, which provides a comprehensive portfolio of engineering and design services across three verticals: Energy Services, Process & Industrial, and Aerospace, Life Sciences and Information Technology and Specialty Health Care Services, engaged in providing the staffing of health care professionals, primarily health information management professionals, nurses, paraprofessionals, physicians. The company generates maximum revenue from the Specialty Health Care segment. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada, Puerto Rico, and Serbia.